middle.news
PolyNovo Accelerates U.S. Sales by 28% as FDA PMA Submission Nears
7:03pm on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
PolyNovo Accelerates U.S. Sales by 28% as FDA PMA Submission Nears
7:03pm on Monday 2nd of June, 2025 AEST
Key Points
U.S. sales surged 27.9% to A$41.2 million in 1H FY25
Rest of World sales rose 28.6%, with new market entries in Malta, Portugal, and Peru
Total group revenue including BARDA reached A$59.9 million, up 22.8% year-on-year
FDA agreed sufficient data exists for PMA approval submission
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Polynovo (ASX:PNV)
OPEN ARTICLE